Imunon Inc
IMNN1.140USD
+0.724+174.37%
收盘 05/23, 16:00（美东）报价延迟15分钟
16.67M总市值
亏损市盈率 TTM
关于 Imunon Inc 公司
Imunon, Inc. 是一家临床阶段的生物技术公司。该公司专注于开发一系列利用人体自然机制治疗一系列人类疾病的治疗方法。该公司正在开发四种模式的非病毒脱氧核糖核酸 (DNA) 技术。第一种模式 TheraPlas 是为治疗实体瘤而开发的蛋白质和细胞因子编码。第二种模式 PlaCCine 是为编码可引发强烈免疫反应的病毒抗原而开发的。第三种模式 FixPlas 涉及应用 Imunon 的 DNA 技术生产通用癌症疫苗，也称为肿瘤相关抗原癌症疫苗。第四种模式 IndiPlas 处于发现阶段，专注于开发个性化癌症疫苗或新表位癌症疫苗。其主要临床项目 IMNN-001 是一种基于 DNA 的免疫疗法，用于局部治疗晚期卵巢癌。
公司简介
公司代码IMNN
公司名称Imunon Inc
上市日期Oct 27, 1993
成立日期2000
CEODr. Stacy R. Lindborg, Ph.D.
员工数量25
证券类型Ordinary Share
年结日Oct 27
公司地址997 Lenox Dr Ste 100
城市LAWRENCEVILLE
上市交易所NASDAQ Capital Market Consolidated
国家United States of America
邮编08648
电话16098969100
网址https://imunon.com/
公司代码IMNN
上市日期Oct 27, 1993
成立日期2000
公司高管
名称
名称/职务
职务
持股
持股变动
Mr. Michael H. Tardugno
Mr. Michael H. Tardugno
Executive Chairman of the Board
Executive Chairman of the Board
69.14K
+66.55%
Dr. Donald P. Braun, Ph.D.
Dr. Donald P. Braun, Ph.D.
Independent Director
Independent Director
25.60K
--
Dr. Sebastien Hazard
Dr. Sebastien Hazard
Executive Vice President, Chief Medical Officer
Executive Vice President, Chief Medical Officer
20.00K
--
Dr. Khursheed Anwer, Ph.D.
Dr. Khursheed Anwer, Ph.D.
Executive Vice President, Chief Scientific Officer
Executive Vice President, Chief Scientific Officer
12.86K
+350.26%
Mr. Frederick J. (Fred) Fritz
Mr. Frederick J. (Fred) Fritz
Independent Director
Independent Director
11.77K
--
Ms. Susan Eylward
Ms. Susan Eylward
General Counsel, Corporate Secretary
General Counsel, Corporate Secretary
--
--
Dr. Stacy R. Lindborg, Ph.D.
Dr. Stacy R. Lindborg, Ph.D.
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
--
--
Mr. David (Dave) Gaiero, CPA
Mr. David (Dave) Gaiero, CPA
Chief Financial Officer
Chief Financial Officer
--
--
Dr. Douglas Vincent Faller, M.D., Ph.D.
Dr. Douglas Vincent Faller, M.D., Ph.D.
Chief Medical Officer
Chief Medical Officer
--
--
Ms. Christine A. Pellizzari, J.D.
Ms. Christine A. Pellizzari, J.D.
Independent Director
Independent Director
--
--
查看更多
名称
名称/职务
职务
持股
持股变动
Mr. Michael H. Tardugno
Mr. Michael H. Tardugno
Executive Chairman of the Board
Executive Chairman of the Board
69.14K
+66.55%
Dr. Donald P. Braun, Ph.D.
Dr. Donald P. Braun, Ph.D.
Independent Director
Independent Director
25.60K
--
Dr. Sebastien Hazard
Dr. Sebastien Hazard
Executive Vice President, Chief Medical Officer
Executive Vice President, Chief Medical Officer
20.00K
--
Dr. Khursheed Anwer, Ph.D.
Dr. Khursheed Anwer, Ph.D.
Executive Vice President, Chief Scientific Officer
Executive Vice President, Chief Scientific Officer
12.86K
+350.26%
Mr. Frederick J. (Fred) Fritz
Mr. Frederick J. (Fred) Fritz
Independent Director
Independent Director
11.77K
--
Ms. Susan Eylward
Ms. Susan Eylward
General Counsel, Corporate Secretary
General Counsel, Corporate Secretary
--
--
收入明细
暂无数据
暂无数据
业务
地区
暂无数据
股东统计
更新时间: 5月16日 周五
更新时间: 5月16日 周五
持股股东
股东类型
持股股东
股东统计
占比
Geode Capital Management, L.L.C.
0.98%
Tardugno (Michael H)
0.47%
BlackRock Institutional Trust Company, N.A.
0.40%
Le (Goff Corinne)
0.36%
The Vanguard Group, Inc.
0.33%
Other
97.45%
持股股东
股东统计
占比
Geode Capital Management, L.L.C.
0.98%
Tardugno (Michael H)
0.47%
BlackRock Institutional Trust Company, N.A.
0.40%
Le (Goff Corinne)
0.36%
The Vanguard Group, Inc.
0.33%
Other
97.45%
股东类型
股东统计
占比
Investment Advisor/Hedge Fund
1.68%
Individual Investor
1.52%
Investment Advisor
0.41%
Venture Capital
0.15%
Hedge Fund
0.10%
Other
96.14%
机构持股
更新时间: 3月3日 周一
更新时间: 3月3日 周一
报告期
机构数
持股数
持股占比
持股变动
2025Q1
49
648.18K
4.43%
-1.83M
2024Q4
52
608.75K
4.16%
-1.78M
2024Q3
50
1.20M
8.34%
-536.74K
2024Q2
48
484.50K
4.81%
-359.07K
2024Q1
49
447.12K
4.68%
-585.60K
2023Q4
59
755.78K
7.96%
-79.04K
2023Q3
65
452.55K
4.85%
-471.22K
2023Q2
68
440.18K
4.85%
-489.81K
2023Q1
80
515.97K
6.03%
-572.90K
2022Q4
81
529.26K
7.22%
-671.21K
查看更多
股东持股明细
名称
持股数
占比
持股变动
变动比例
公告日期
Geode Capital Management, L.L.C.
139.50K
0.95%
+13.57K
+10.78%
Dec 31, 2024
Tardugno (Michael H)
69.14K
0.47%
+27.63K
+66.55%
Feb 21, 2025
BlackRock Institutional Trust Company, N.A.
58.22K
0.4%
--
--
Dec 31, 2024
Le (Goff Corinne)
53.00K
0.36%
--
--
Feb 21, 2025
The Vanguard Group, Inc.
48.81K
0.33%
--
--
Dec 31, 2024
Lindborg (Stacy R. Ph.D.)
28.06K
0.19%
+3.06K
+12.22%
Feb 21, 2025
Braun (Donald P)
25.60K
0.18%
--
--
Feb 21, 2025
XTX Markets LLC
21.41K
0.15%
+21.41K
--
Dec 31, 2024
Northern Trust Investments, Inc.
21.64K
0.15%
+18.40K
+567.70%
Dec 31, 2024
State Street Global Advisors (US)
21.30K
0.15%
--
--
Dec 31, 2024
查看更多
持股ETF
更新时间: 5月6日 周二
更新时间: 5月6日 周二
机构名称
占比
iShares Core S&P Total U.S. Stock Market ETF
0%
iShares Core S&P Total U.S. Stock Market ETF
占比0%
分红派息
近5年累计派现
0.00
美元
公告日期
分红计划
股权登记日
现金发放日
除权除息日
暂无数据
拆合股
公告日期
类型
比率
Feb 28, 2022
Merger
15<1
Feb 28, 2022
Merger
15<1
Feb 28, 2022
Merger
15<1
Feb 28, 2022
Merger
15<1
公告日期
类型
比率
Feb 28, 2022
Merger
15<1
Feb 28, 2022
Merger
15<1
Feb 28, 2022
Merger
15<1
Feb 28, 2022
Merger
15<1
